| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2005 | Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters | Shie, J. J.; Fang, J. M.; Kuo, T. H.; Kuo, C. J.; Liang, P. H.; Huang, H. J.; Wu, Y. T.; Jan, J. T.; Cheng, Y. S.; Wong, C. H. | BIOORGANIC & MEDICINAL CHEMISTRY 13, 5240-5252 | | | |
| 2004 | Small molecules targeting severe acute respiratory syndrome human coronavirus | Wu, C. Y.; Jan, J. T. ; Ma, S. H.; Kuo, C. J.; Juan, H. F.; Cheng, Y. S.; Hsu, H. H.; Huang, H. C.; Wu, D.; Brik, A.; Liang, F. S.; Liu, R. S.; Fang, J. M.; Chen, S. T. ; Liang, P. H. ; Wong, C. H. | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
101(27), 10012-10017 | | | |
| 2006 | Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Stndrome 3CL Protease | Wu, Chung-Yi; King, K. Y.; Kuo, C. J.; Fang, J. M.; Wu, Y. T.; Ho, M. Y.; Liao, C. L.; Shie, J. J.; Liang, P. H.; Wong, C. H. | Chem Biol 13, 261-268 | | | |
| 2006 | Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease | Wu, C. Y.; King, K. Y.; Kuo, C. J.; Liang, P. H.; Wu, Y. T.; Ho, M. Y.; Liao, C. L.; Fang, J. M.; Wong, C. H. | Chem Biol 13, 261-268 | | | |
| 2005 | Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors | Chen, L. R.; Wang, Y. C.; Lin, Y. W.; Chou, S. Y.; Chen, S. F.; Liu, L. T.; Wu, Y. T.; Kuo, C. J.; Chen, T. S.; Juang, S. H. | Bioorg Med Chem Lett 15, 3058-3062 | | | |
| 1999 | Validity of the CAGE questionnaire in a primary care setting in Taiwan: a cross-cultural examination | Kuo, C. J.; Chen, W. J.; Cheng, A. T. A. | Chinese Journal of Public Health 18, 87-94 | | | |
